Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0001104659-15-081132

Director acquired 564,948 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Coleman Mark Director 2015-11-24 Conversion +243,750 $5.40 $1,316,250 326,800 D
Coleman Mark Director 2015-11-24 Conversion +180,526 $5.94 $1,072,324 507,326 D
Coleman Mark Director 2015-11-24 Conversion +140,672 $5.94 $835,592 647,998 D
Derivatives
Coleman Mark Director 2015-11-24 Grant or award · 8% Convertible Note +243,750 0 D
Coleman Mark Director 2015-11-24 Grant or award · 8% Convertible Note +180,526 0 D
Coleman Mark Director 2015-11-24 Grant or award · 8% Convertible Note +140,672 0 D
Loading xslF345X03/a4.xml…